IL10 and chronic hepatitis C virus infection: A study from 2013 reported an inverse correlation between IL-10 levels and fibrosis stages in patients with CHC, while another showed that treatments with an IL-10 agonist reveal a decrease in fibrosis progression in chronic hepatitis C virus infection [26,44].